Current status and prospects of diagnosis, treatment and management of Helicobacter pylori infection in China
10.3760/cma.j.cn114798-20250328-00259
- VernacularTitle:我国幽门螺杆菌感染诊治及管理的现状和未来
- Author:
Yi HU
1
;
Yuchen ZHU
;
Yin ZHU
Author Information
1. 消化疾病江西省重点实验室 南昌大学第一附属医院消化内科，南昌 330006
- Publication Type:Journal Article
- Keywords:
Helicobacter pylori;
Stomach neoplasms;
Screening;
Diagnosis;
Eradication therapy
- From:
Chinese Journal of General Practitioners
2025;24(7):778-784
- CountryChina
- Language:Chinese
-
Abstract:
Helicobacter pylori ( H. pylori) is a major pathogenic factor in gastric diseases, infecting approximately half of the global population. As a country with a high incidence of gastric cancer and high prevalence of H. pylori, China exhibits a familial clustering pattern of H. pylori infection and faces challenges of severe antibiotic resistance, and insufficient awareness among primary healthcare providers and the general public. This review summarizes the epidemiological profile, screening and eradication strategies, clinical diagnosis and treatment practices, and novel eradication therapies of H. pylori infection based on domestic and international consensus and research advances in the field.
